Connect with us

Technology

HealthVerity introduces taXonomy, the nation’s most comprehensive closed claims dataset for pharmaceutical research

Published

on

PHILADELPHIA, June 24, 2024 /PRNewswire/ — HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced the launch of HealthVerity taXonomy – the nation’s most comprehensive, highly-curated and research-ready closed claims dataset for pharmaceutical safety, real-world evidence, and health economics and outcomes research organizations. This next-generation data solution meets the needs of an industry facing headwinds with evolving and unstable access to HIPAA-compliant patient data that is critical to justifying the cost, effectiveness and safety of increasingly complex treatments. HealthVerity taXonomy overcomes these challenges while providing unparalleled insights into patient journeys, treatment outcomes and total cost of care.

Breaking from legacy solutions that rely on a narrow mix of payers and payer types, HealthVerity taXonomy is an easy-to-use dataset specifically designed for research that encompasses over 245 million patient journeys from more than 225 payers, including commercial, Medicare and Medicaid, as well as race and mortality markers. The expansive dataset has up to eight years of continuous coverage, inclusive of all age groups, races and geographies. These attributes ensure a superior volume of rare and orphan diseases compared to legacy solutions, allowing for more impactful research outcomes. Through HealthVerity’s curation process, researchers benefit from organized, well-structured, de-duplicated patient encounters, reducing data management time and complexity.

Addressing a disruptive trend in data access, HealthVerity taXonomy is built for the long-term with a matrix approach to data providers that maximizes data breadth and stability while minimizing data disruption. HealthVerity has lasting relationships with all of the data providers in the nation’s largest healthcare and consumer data ecosystem that leads to a seamless data experience for its clients. Moreover, the open HealthVerity data ecosystem continually supports new payers and fully interoperable data types, such as electronic medical records and lab results, ensuring that HealthVerity taXonomy can solve for the most challenging of research questions in the most consistent, well characterized and highly relevant manner.

HealthVerity taXonomy also includes improved standardized costs mapped to procedures for any geography or payer type, including relevant market averages. This level of cost standardization enables pharmaceutical companies to better understand the pricing and value of medical treatments and total cost of care, ultimately leading to improved results.

HealthVerity taXonomy offers a newly streamlined and industry-leading data model with all data attributes being fully synchronized, de-duped and HIPAA-certified. This makes HealthVerity taXonomy research-ready from day one. The HIPAA certification also covers any future payer and data type additions from HealthVerity, ensuring continued compliance with privacy regulations while avoiding lengthy privacy delays in gaining access to new patient insights. 

“With the changing pharmaceutical and healthcare data landscape, researchers can no longer afford to rely on legacy closed claims datasets derived from limited data sources and lacking key attributes from commercial, Medicare and Medicaid patients,” said Andrew Kress, CEO of HealthVerity. “We are excited to be able to offer HealthVerity taXonomy as the industry’s most comprehensive, highly-curated and research-ready closed claims dataset premier for the study of efficacy, safety and economic outcomes.”

With taXonomy, HealthVerity is taking a bold step towards improving the landscape for healthcare data and delivering transformative results for the industry. To learn more, register for our webinar on Wednesday, July 10 at 12:00 p.m. ET, where we will reveal key details about HealthVerity taXonomy.

About HealthVerity

HealthVerity synchronizes transformational technologies with the nation’s largest healthcare and consumer data ecosystem to power previously unattainable outcomes and fundamentally advance the science. We offer a comprehensive, yet flexible approach, based on the foundational elements of Identity, Privacy, Governance and Exchange (IPGE), that synchronizes unparalleled Identity management with built-in Privacy compliance and Governance, providing the ability to discover and Exchange a near limitless combination of data at a record pace. Together with our partners in life sciences, government and insurance, we are Synchronizing the Science. To learn more about HealthVerity, visit healthverity.com.

HealthVerity Contact:
Colleen Stoker
614-738-0592
cstoker@healthverity.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthverity-introduces-taxonomy-the-nations-most-comprehensive-closed-claims-dataset-for-pharmaceutical-research-302179467.html

SOURCE HealthVerity

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Ganzin Unveils Revolutionary AURORA IIS Eye-Tracking Solution at CES 2025

Published

on

By

Ganzin will announce AURORA IIS solution in CES 2025, which is a new NPU eye-tracking solution, that only composed of one NPU, two eye sensors, and two IR LEDs. The host could receive eye-tracking results from the NPU directly without any computational burden. It is an ideal eye-tracking solution for AR and AI smartglasses.The NPU’s dimension is just 2.3 x 5.6 mm, the eye sensor’s dimension is 1.6 x 1.6 x 2.3mm, and the IR LED’s dimension is 1 x 0.5 x 0.45mm.DPVR, a leading Chinese VR brand, is set to announce its new standalone VR model, the P2 Vision. The device features advanced eye-tracking technology, powered by the Ganzin AURORA IIS solution.P2 Vision is orderable since CES 2025. You are welcome to visit DPVR booth to experience P2 Vision and Ganzin eye tracking performance at LVCC, Central Hall – 15945.

TAIPEI, Dec. 27, 2024 /PRNewswire/ — Ganzin, a pioneer in glint-free wearable eye-tracking technology provider, is proud to announce the launch of its groundbreaking AURORA IIS solution at CES 2025. This cutting-edge system redefines simplicity and performance in eye-tracking, requiring only one compact NPU, two eye sensors, and two IR LEDs to deliver real-time eye-tracking results to the host device without any computational burden. It is an ideal eye-tracking solution for AR and AI smartglasses.

The NPU, with an ultra-compact size of just 2.3 x 5.6 mm, is purpose-built for AI/AR glasses, and VR headsets. The accompanying eye sensors measure a mere 1.6 x 1.6 x 2.3 mm, while the IR LEDs are 1 x 0.5 x 0.45 mm. The entire AURORA IIS solution weighs less than 1 gram and consumes under 100 mW of power, delivering exceptional efficiency for next-generation wearable devices.

In a major collaboration, DPVR, one of China’s most prominent VR brands, will debut its latest standalone VR model, the P2 Vision, at CES 2025. The P2 Vision incorporates Ganzin’s AURORA IIS solution, enabling precise, real-time eye-tracking capabilities that enhance user interaction, gaze-based control, and immersive experiences.

Visitors to CES 2025 are invited to experience the P2 Vision and Ganzin’s innovative eye-tracking technology in action. Live demonstrations will be held at the DPVR booth (LVCC, Central Hall – 15945), where attendees can get a hands-on look at the future of VR interaction. The P2 Vision will also be available for order starting at CES 2025, marking a new era for VR accessibility and functionality.

“The AURORA IIS marks a major breakthrough in eye-tracking technology,” said Dr. Shao-Yi Chien, CEO of Ganzin. “Our ultra-compact, energy-efficient solution is tailored to meet the demands of VR, AR, and wearable device manufacturers. We also offer flexible customization of eye camera placement to integrate with our clients’ industrial design (ID) requirements.”

Ganzin will have a private suite at the Westgate Hotel during CES 2025. To learn more about our AURORA IIS solution or to schedule a private demonstration, please reach out to our contact listed below.

Media Contact: Martin Lin
Business Development Manager
Ganzin Technology Co., Ltd.
Email: martin.lin@gnainz.com.tw 

About Ganzin

Ganzin is a global leader in eye-tracking technology, delivering advanced, compact, and energy-efficient solutions for next-generation wearable and immersive devices. The company’s vision is to make human-machine interaction more intuitive and accessible to everyone, enabling smarter and more responsive user experiences for consumers.

About DPVR

DPVR is a leading virtual reality technology company based in China, renowned for its development of user-friendly, high-performance VR headsets. Committed to bringing immersive experiences to the masses, DPVR continues to push the boundaries of VR technology and innovation.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ganzin-unveils-revolutionary-aurora-iis-eye-tracking-solution-at-ces-2025-302339520.html

SOURCE Ganzin Technology

Continue Reading

Technology

Eddid Financial Partners with HKBU for the Third Consecutive Year to Establish 10th Anniversary Scholarship

Published

on

By

HONG KONG, Dec. 27, 2024 /PRNewswire/ — Building on successful collaborations with the School of Oriental and African Studies (“SOAS”) at the University of London, Hong Kong University of Science and Technology, The Hong Kong Polytechnic University, and City University of Hong Kong, Eddid Financial (the “Group”) announces its partnership with Hong Kong Baptist University (“HKBU”). The Group and HKBU have, together, established the “Eddid Financial 10th Anniversary Scholarship” for the 2024/25 academic year to recognize students who excel academically and contribute outstandingly to social service.

Over the past three years, the Group has engaged in various initiatives with HKBU, including the establishment of social service scholarships, fintech research projects, and internship programs. As Edidd Financial approaches its 10th anniversary in 2025, this new scholarship underscores their commitment to deepening collaboration. This “Eddid Financial 10th Anniversary Scholarship” will reward third-year undergraduate students from the business school who demonstrate academic excellence and a dedication to community service, inspiring more students to strive for success while giving back to society.

The Group is deeply committed to nurturing the next generation of talent and looks forward to supporting those who pursue excellence and are passionate about serving the community in the future academic year. Eddid Financial will also maintain close communication and collaboration with HKBU to support its teaching and research efforts, contributing to sustainable development in society.

About Eddid Financial

Anchored in Hong Kong, Eddid Financial is an all-encompassing financial group centered around fintech and dedicated to integrating cutting-edge artificial intelligence technologies and other latest technologies into its enterprise DNA. The diversified businesses of Eddid Financial range from retail to institutional and include but are not limited to fintech, internet finance, wealth management, asset management, investment banking, and virtual assets. Eddid Financial is committed to providing one-stop financial services and products to customers through high-quality investment solutions.

Members of the Group hold a variety of licenses and memberships across key financial markets. These include Hong Kong Securities and Futures Commission (SFC) regulated activities (“RA”) licenses for types 1, 2, 3, 4, 5, 6, and 9; SEHK and HKCC participant (OTP-C broker number: 0974 and 0977), Insurance Broker Company license; Trust or Company Service Provider License in Hong Kong. Additionally, our fully owned U.S. broker-dealer subsidiary, Eddid Securities USA Inc., maintains approved membership with the Financial Industry Regulatory Authority (FINRA), the National Futures Association (NFA), and the Securities Investor Protection Corporation (SIPC), and the Nasdaq Stock Market LLC (NQX), and is a registered broker dealer with the U.S. Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC) in the United States.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/eddid-financial-partners-with-hkbu-for-the-third-consecutive-year-to-establish-10th-anniversary-scholarship-302339531.html

SOURCE Eddid Financial

Continue Reading

Technology

JinkoSolar Announces Results of 2024 Annual General Meeting

Published

on

By

SHANGRAO, China, Dec. 27, 2024 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that all shareholders resolutions proposed at the Company’s 2024 annual general meeting held today were duly passed. Specifically, the Company’s shareholders passed the following resolutions approving:

The re-election of Mr. Xianhua Li as a director of the Company;The re-election of Mr. Steven Markscheid as a director of the Company;The ratification of the appointment of Mr. Gang Chu as an independent director of the Company and the re-election of him as an independent director of the Company;The ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2024;The authorization of the directors of the Company to determine the remuneration of the auditors of the Company; andThe authorization of each of the directors of the Company be authorized to take any and all action that might be necessary to effect the foregoing resolutions 1 to 5 as such director, in his or her absolute discretion, thinks fit.

 About JinkoSolar Holding Co., Ltd.

JinkoSolar (NYSE: JKS) is one of the largest and most innovative solar module manufacturers in the world. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, Netherlands, Poland, Austria, Switzerland, Greece and other countries and regions.

JinkoSolar had over 10 productions facilities globally, over 20 overseas subsidiaries in Japan, South Korea, Vietnam, India, Turkey, Germany, Italy, Switzerland, the United States, Mexico, Brazil, Chile, Australia, Canada, Malaysia, the United Arab Emirates, Denmark, Indonesia, Nigeria and Saudi Arabia, and a global sales network with sales teams  in China, the United States, Canada, Brazil, Chile, Mexico, Italy, Germany, Turkey, Spain, Japan, the United Arab Emirates, Netherlands, Vietnam and India, as of September 30, 2024. To find out more, please see: www.jinkosolar.com

For investor and media inquiries, please contact:

In China:

Ms. Stella Wang
JinkoSolar Holding Co., Ltd.
Tel: +86 21-5180-8777 ext.7806
Email: ir@jinkosolar.com 

Mr. Rene Vanguestaine
Christensen
Tel: +86 178 1749 0483
Email: rene.vanguestaine@christensencomms.com  

In the U.S.:

Ms. Linda Bergkamp
Christensen, Scottsdale, Arizona
Tel: +1-480-614-3004
Email: linda.bergkamp@christensencomms.com

View original content:https://www.prnewswire.com/news-releases/jinkosolar-announces-results-of-2024-annual-general-meeting-302339506.html

SOURCE JinkoSolar Holding Co., Ltd.

Continue Reading

Trending